An official website of the United States government
Home
Name
CLAG
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for CLAG
Name
Alternate Names
2-Chlorodeoxyadenosine
Chlorodeoxyadenosine
CldAdo
Leustatin
RWJ 26251
RWJ-26251
RWJ26251
Abbreviations
2CdA
Category
Chemotherapy
Subcategory
Antimetabolite
purine analogs
NSC Number
105014
Primary Site
Leukemia
Leukemic reticuloendotheliosis
Histology
None
Remarks
FDA approved for hairy cell leukemia treatment.
Currently in trials for other B cell leukemias and lymphomas, such as mantle cell lymphoma. Also used in the treatment of multiple sclerosis.
Currently in trials for other B cell leukemias and lymphomas, such as mantle cell lymphoma. Also used in the treatment of multiple sclerosis.
Coding
This drug should be coded
Name
Alternate Names
AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453
Abbreviations
ara-C
CA
HDA
HDARA-C
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
063878
63878
Primary Site
Histology
None
Remarks
Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)
Coding
This drug should be coded
